Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;130(8):1539-1550.
doi: 10.1002/jso.27855. Epub 2024 Sep 10.

A Systematic Review of Surgical and Pathological Outcomes in Patients With a CDH1 Mutation Undergoing Total Gastrectomy

Atousa Khiabany  1 , Alexander A Dermanis  1 , Mei Sien Liew  1 , Kai Ren Ong  2 , Sivesh K Kamarajah  1   2 , Ewen A Griffiths  1   2
Affiliations

A Systematic Review of Surgical and Pathological Outcomes in Patients With a CDH1 Mutation Undergoing Total Gastrectomy

Atousa Khiabany et al. J Surg Oncol. 2024 Dec.

Abstract

Background: CDH1 (E-cadherin) genetic mutations are associated with a 30%-70% increased lifetime risk of hereditary diffuse gastric cancer (HDGC). Although prophylactic total gastrectomy (PTG) reduces long-term risk of gastric cancer, the associated morbidity and mortality remain unclear. This systematic review aims to characterise postoperative surgical outcomes in patients undergoing total gastrectomy.

Methods: A systematic literature search was performed for studies reporting endoscopic surveillance, surgical and pathological outcomes for patients with CDH1 mutation undergoing a total gastrectomy.

Results: Thirty-nine studies included 1849 patients, of which 96% had a CDH1 (n = 1777) or CTNNA1 (n = 3) mutation. Endoscopy outcomes were reported for 1640 patients. Cancer foci were identified in 32% (n = 523/1640) and 71% of these patients went on to have a total gastrectomy (n = 369/523). The remaining 78% of patients did not have cancer foci detected on endoscopy (n = 1117/1640). Of these patients, 62% underwent a total gastrectomy (n = 688/1117) and 81% were found to have cancer on surgical histology (n = 556/688). Pathological staging was reported for 790 patients undergoing surgery, of which 68% had pT1 disease (n = 537). Postoperative complications were reported for 430 patients across 23 studies, with the most common complications being anastomotic strictures (25%), anastomotic leaks (13%), wound infections (12%) and pulmonary complications (11%). Only one postoperative death was reported within 30 days.

Conclusion: Rates of early cancers are high in CDH1 patients undergoing PTG, highlighting the need for improvement in reliable endoscopic surveillance. Although postoperative mortality in this surgical cohort remains low, high rates of postoperative complications warrant careful patient counselling.

Keywords: CDH1 mutations; gastrectomy; overall survival.

PubMed Disclaimer

References

    1. V. R. Blair, M. McLeod, F. Carneiro, et al., “Hereditary Diffuse Gastric Cancer: Updated Clinical Practice Guidelines,” Lancet Oncology 21, no. 8 (August 2020): e386–e397.
    1. I. J. Majewski, I. Kluijt, A. Cats, et al., “An α‐E‐Catenin (CTNNA1) Mutation in Hereditary Diffuse Gastric Cancer,” Journal of Pathology 229, no. 4 (March 2013): 621–629.
    1. T. Lecuit and A. S. Yap, “E‐Cadherin Junctions as Active Mechanical Integrators in Tissue Dynamics,” Nature Cell Biology 17, no. 5 (May 2015): 533–539.
    1. P. D. P. Pharoah, P. Guilford, C. Caldas, and International Gastric Cancer Linkage Consortium, “Incidence of Gastric Cancer and Breast Cancer in CDH1 (E‐Cadherin) Mutation Carriers From Hereditary Diffuse Gastric Cancer Families,” Gastroenterology 121, no. 6 (December 2001): 1348–1353.
    1. W. Eijzenga, D. E. Hahn, N. K. Aaronson, I. Kluijt, and E. M. Bleiker, “Specific Psychosocial Issues of Individuals Undergoing Genetic Counseling for Cancer: A Literature Review,” Journal of Genetic Counseling 23 (2014): 133–146.

Publication types

LinkOut - more resources